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Aim: The aim of the present study was to investigate the long-term efficacy of rapid maxillary expansion (RME) and facemask 
(FM) therapy in the treatment of Class III malocclusions by comparing Class III subjects treated by RME/FM mechanics with 
untreated Class III controls at the Western Australian public dental hospital.
Materials and methods: The lateral cephalograms of 42 (26 males, 16 females) Class III patients treated by RME/FM therapy 
were analysed and compared with a control sample comprised of 23 (14 males, 9 females) untreated Class III patients. 
Evaluations were carried out prior to facemask therapy and at a long-term follow-up period of approximately eight to nine years 
post-treatment. Statistical comparisons were performed using t-tests for unpaired data.
Results: At long-term follow-up, there were no statistically significant differences between the treated and control groups except in 
overjet, which was greater in the treated group (p < 0.05).
Conclusions: These results suggest that the short-term effects on the maxilla in RME/FM therapy are not maintained in the long 
term. Success in treatment is largely dependent on the patient’s skeletal growth pattern.
(Aust Orthod J 2020; 36:  27-37)
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Introduction
Facemask therapy is a commonly used form of 
interceptive treatment for the management of a 
Class III malocclusion in the growing child. The 
fundamental principles of Class III early treatment are 
based on the premise that growth of the dentofacial 
skeleton can be manipulated. The goal of RME/FM 
therapy is firstly to improve the Class III skeletal 
discrepancy by influencing the increment and 
direction of facial growth.1 Secondly, therapy aims 
to improve occlusal function by the elimination of a 
functional shift and to simplify phase II conventional 
treatment.2 Lastly, it aims to provide more pleasing 
facial aesthetics, thereby improving the psychological 
development of the child,3 although there is previous 
evidence that Class III early intervention does not 
appear to confer a significant psychosocial benefit.4 
The ability to alter basal skeletal relationships by 
interceptive treatment is largely based on work by 
Melsen, who showed in histological findings that the 
midpalatal suture is broad and smooth during infancy 
(8–10 years) and eventually becomes more squamous 
and interdigitated in the juvenile stage (10–13 years).5 
Moreover, several animal studies have shown that 
the maxillary complex can be displaced anteriorly 
with significant changes noted in the facial sutures 
associated with the nasomaxillary complex.6-10
The treatment effect of RME/FM therapy is primarily 
to orthopaedically advance the maxilla. This occurs 
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with an associated concurrent maxillary rotation, 
which depends on the direction of the applied force 
vector in relation to the centre of resistance of the 
maxilla. This can be adjusted according to the desired 
clinical effect planned for the specific case. For 
example, maintaining a force vector of approximately 
5–20 mm above the occlusal plane facilitates a parallel 
movement of the maxilla that is suited to patients with 
a hyperdivergent skeletal pattern and/or an anterior 
open bite tendency. Alternatively, maintaining a force 
vector angle of 20–30 degrees below the occlusal 
plane would generate a counter-clockwise rotation 
of the maxilla.11 The downward vertical movement 
of the maxilla results in a downward and backward 
rotation of the mandible leading to dental changes 
that are favourable for the correction of a Class III 
malocclusion and deep overbite.12
There have been several studies reporting the 
effectiveness of facemask therapy in the early 
management of a Class III malocclusion in a growing 
child.12-17 Nonetheless, there is still uncertainty related 
to the long-term stability of the dental and skeletal 
changes as a result of facemask therapy.
Despite being shown to be effective in the initial stages 
of treatment, the reported results are not maintained 
in the long term in 30% of Class III patients.4,13,16 
The most common cause of failure following 
facemask therapy is late mandibular growth in a 
horizontal direction, often indicated by the presence 
of an increased posterior vertical height, length of the 
mandibular ramus, angulation of the cranial base and 
the inclination of the mandibular plane to the cranial 
base.12,13,18 
The purpose of this retrospective observational study 
was to investigate the long-term efficacy of RME/FM 
mechanics in the treatment of Class III malocclusions. 
By comparing Class III patients treated using RME/
FM with untreated Class III controls, it was expected 
that a greater insight into the dental and facial changes 
would be revealed through long-term follow-up.
Material and methods
Approval was obtained from the Human Research 
Ethics Committee of Western Australia in accordance 
with the requirements from the National Statement 
on Ethical Conduct in Human Research (National 
Statement) and the policies and procedures of the 
University of Western Australia. 
The lateral cephalograms of 42 (26 males, 16 females) 
Class III patients, with a mean age of 8.8 years, treated 
using RME/FM therapy were analysed and compared 
with a control sample comprised of 23 (14 males, 9 
females) untreated Class III patients, with a mean age 
of 10.3 years. The records of the treated group were 
obtained from a private practice in Perth, Australia 
and the untreated group from the dental school clinic 
in Western Australia. 
The sample selection criteria for the treatment group 
included
• A Class III malocclusion at the first observation 
(Ti) characterised by an anterior crossbite or 
edge-to-edge incisal relationship and a Wits 
appraisal of -2 mm or less
• Interceptive treatment with RME/FM therapy
• No permanent or congenitally missing teeth
• Cephalograms of adequate quality available 
at Ti before RME/FM and at the long-term 
observation (Tf ), at least six years after RME/
FM 
The untreated Class III control group was screened 
by similar criteria except that RME/FM therapy 
was not undertaken, and this cohort was followed 
longitudinally. Early interceptive treatment was not 
commenced in these patients because the families 
could not afford, or alternatively refused, treatment.
The treatment protocol involved the use of a bonded 
RME and a facemask, with a forward force vector 
directed approximately 30 degrees below the occlusal 
plane. The treatment was continued until the initial 
negative overjet was overcorrected by at least 2 mm, 
as suggested by previous studies.18-25 The expansion 
regime involved two turns per day for one week, 
followed by two turns per week until the desired 
overexpanded width was achieved. 
An analysis of 32 cephalometric variables was 
conducted of predetermined cephalometric points. 
All radiographs were hand traced and analysed by 
the principal investigator (BL). The landmarks and 
reference planes used are illustrated in Figures 1 and 
2, respectively. Changes in the skeletal and dental 
measurements were recorded in relation to the 
occlusal plane superior (OLs) and the occlusal plane 
perpendicular (OLsp) according to the method of 
Pancherz.26,27
Patients who experienced significant growth resulting 
in a recurrence or development of a significant 
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negative overjet and/or self-perceived deterioration of 
their facial aesthetics were considered for surgery.
Statistical analysis
Sample means were calculated for each variable at 
the initial (Ti) and final visit (Tf ), in addition to 
changes for each variable during this time period. 
Subsequently, the treatment group was divided into 
patients who required surgery and those who were 
treated non-surgically after RME/FM treatment. 
Independent samples t-tests were applied to determine 
any significant differences between the two groups 
in the cephalometric variables obtained at the initial 
and final visits. Bonferroni corrections were carried 
out on the t-tests to reduce the possibility that any 
significance was due to chance. The relationship 
between the change in maxillary base and each group 
was investigated using linear mixed effects models 
after adjusting for a change in age between visits. 
The method error was measured by repeating the 
cephalometric measurements of pre- and post-
treatment lateral cephalograms on a random selection 
of 10 patients (N = 20). Statistical analysis was 
undertaken using statistical software (R for Windows 
2.15.2, R Foundation for Statistical Computing, 
Vienna, Austria),28 testing at the 95% confidence level 
(p < 0.05).
Results
There were no statistically significant differences in the 
cephalometric values between the treated and control 
subjects at baseline (Ti) (Table I). At the long-term 
follow-up, the only statistically significant difference 
in cephalometric values between the treated and 
control groups was overjet, with the overjet greater 
in the treated group (p < 0.05, Table I). There was 
a significant difference in age between the untreated 
and treated groups at baseline (Ti) and at the final visit 
(Tf ). At baseline, the untreated group was on average 
approximately 1.5 years older, whilst at Tf, untreated 
subjects were younger (Table II). Nonetheless, the 
relationship between a change in the maxillary base 
and each group was investigated using a longitudinal 
analysis with linear mixed models. This was done 
because of the number of complex predictors with 
variations in distribution that revealed no significant 
differences between the control and treated groups, 
even when age was taken into consideration (Figure 
3, Tables III–V). 
When the treatment group was subdivided into 
surgical and non-surgical groups, at Ti the surgical 
group presented with a greater AB distance discrepancy 
and greater soft tissue convexity (p < 0.05). Although 
the overbite was detected as statistically different 
between groups, it was not clinically significant (p < 
0.05, Table VI). At long-term follow-up, the Class III 
skeletal pattern worsened in the surgical group with 
cephalometric variables Mx/Mn relationship (p 
< 0.01), ANB (p < 0.01), AB distance (p < 0.01), 
Wits (p < 0.01), soft and hard tissue convexity (p < 
0.05), overjet (p < 0.01), molar relation (p < 0.01) 
and inclination of the mandibular incisors (p < 0.01) 
Figure 1. Cephalometric reference points used in the study.
Figure 2. Cephalometric reference lines related to OLsp used in the study.
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Cephalometric variable
Control  (CG) 
at Ti N=23
Treated (TG) at 
Ti N=42
Control  (CG) 
at Tf  N=23







at TfMean SD Mean SD Mean SD Mean SD
Maxillary skeletal
Maxillary Base (ss/OLsp) 66.2 5.6 65.4 4.4 70.6 5.0 70.4 5.5 NS NS
SNA 79.2 3.4 79.2 3.8 80.1 3.5 80.9 4.1 NS NS
Mandibular skeletal
Md base (Pg/OLsp) 76.2 7.8 75.8 6.9 85.5 7.4 83.9 8.7 NS NS
Md length (Pg-co/OLsp) 82.3 7.1 82.9 6.1 93.8 7.5 94.3 8.7 NS NS
SNB 80.5 3.3 80.8 3.4 82.6 5.0 83.2 4.2 NS NS
B point/Olsp 74.1 7.2 73.0 5.0 80.7 6.5 79.1 7.6 NS NS
SNPg 81.0 3.4 81.4 3.7 83.7 5.0 84.3 4.3 NS NS
Maxillomandibular
Mx/Mn relationship  (ss-Pg/OLsp) -10.1 5.1 -10.4 4.2 -14.9 6.1 -13.6 6.4 NS NS
ANB -1.3 3.3 -1.7 2.5 -2.4 3.6 -2.1 3.4 NS NS
AB distance -1.2 4.1 -0.3 2.7 -4.1 6.0 -2.5 5.4 NS NS
Wits -7.9 4.2 -7.5 2.2 -10.1 4.8 -8.8 5.2 NS NS
Hard tissue convexity 
(n-ss-Pg) -4.9 7.6 -4.3 5.3 -7.8 6.4 -7.1 7.7 NS NS
Vertical skeletal
Nasal plane angle (NL/NSL) 7.3 2.9 6.6 3.1 6.8 3.1 6.7 3.3 NS NS
Md plane angle (ML/NSL) 36.1 3.7 35.5 4.2 35.1 5.0 34.3 4.8 NS NS
Vertical jaw relation (ML/NL) 28.7 4.5 28.6 3.6 28.1 5.5 27.3 5.0 NS NS
LAFH (sp-gn/NSL) 56.5 2.6 56.2 2.0 57.9 2.2 57.0 2.3 NS NS
Skeletodental
Mx incisor horizontal (is/OLsp) 73.3 6.5 71.5 5.2 79.7 6.1 79.1 7.0 NS NS
ls.OLsp 85.3 7.3 83.3 5.0 92.1 5.5 90.1 7.3 NS NS
Mx molar horizontal (ms/OLsp) 47.5 6.0 45.4 3.8 54.3 5.5 52.5 5.0 NS NS
Md incisor horizontal (ii/OLsp) 74.4 5.9 72.5 4.9 81.2 5.9 78.9 7.5 NS NS
li.OLsp 88.0 8.0 86.0 5.3 96.0 6.4 92.9 8.1 NS NS
Md molar horizontal (mi/OLsp) 51.0 6.3 48.5 4.2 60.2 7.1 57.4 6.4 NS NS
Dentoalveolar
Inclination max. inc. to NSL (ILis-NSL) 112.0 6.5 112.4 8.7 117.1 5.7 117.4 6.3 NS NS
Inclination mand. inc. to ML (ILii-ML) 85.4 6.6 84.0 6.4 83.9 7.8 82.3 8.6 NS NS
Interdental
Overjet -1.1 2.5 -1.0 2.2 -1.5 3.4 0.3 2.7 NS *
Molar relation  (ms/OLsp-mi/OLsp) -3.6 3.1 -3.0 2.0 -5.9 4.1 -4.8 2.8 NS NS
Overbite (is-ii/OLsp) 2.0 3.3 1.0 2.1 0.8 2.4 1.0 2.3 NS NS
Soft tissue
Soft tissue convexity w/out nose (n’-ss’-pg) 8.8 8.1 6.4 7.6 7.7 6.6 6.3 7.4 NS NS
Soft tissue convexity with nose (n’-pro-Pg’) 41.6 6.3 41.7 4.5 42.2 6.1 43.9 6.0 NS NS
ss’/OLsp 80.4 6.3 78.7 4.8 87.0 5.4 85.5 6.9 NS NS
pg’/OLsp 87.2 8.0 85.2 6.1 96.8 8.0 94.6 8.9 NS NS
Table I.  Comparison between treatment and control groups at Ti and Tf.
* p < 0.05; **p < 0.01; #Significant with the Bonferroni correction; NS = not significant
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significantly different compared with the non-surgical 
group (Table VI). However, no significant differences 
in maxillary change were observed (Figure 4).
Discussion
The objective of early orthodontic treatment is to create 
a favourable dentofacial environment to prevent the 
adaptations and limitations that are often associated 
with malocclusion later in life.1 However, whether 
RME/FM therapy can modify and influence growth 
of the maxilla beyond its predetermined position 
and length is a contentious issue, particularly since 
many of the studies do not provide long-term data 
on whether the positional correction is maintained 
and  is any different to that resulting from normal 
maxillary growth.
Despite being effective in the initial stages of 
treatment,17,20, 29-32 the literature has demonstrated that 
the results are not maintained in the long term in 30% 
of patients who present with a Class III malocclusion. 
This group likely requires orthognathic surgical 
consideration and intervention.4,13,16 In addition, a 
recent case report involving twins with identical Class 
III malocclusions demonstrated that, despite only 
one twin receiving facemask therapy, both patients 
achieved almost identical dentofacial results at the 
age of 18 years. However, both received a full course 
of full fixed appliances.2 Even though this was a case 
report, it questioned whether facemasks are able to 
significantly alter the inherited craniofacial skeleton 
of the growing child on a permanent basis.34
More recently, Masucci et al. observed no statistically 
significant difference in the position of the maxilla 
between RME/FM treated and untreated groups at the 
completion of growth.35 These findings are consistent 
with those found in the present study, in which no 
Age Control (N=23) Treated (N=42)
Mean SD Mean SD p-value
Age at Ti 10.32 1.57 8.77 1.17 <0.001*
Age at Tf 16.97 2.03 18.12 2.30 0.049*
Table II.  Comparison between treatment and control groups at Tf.
Mixed effect modelling of Maxillary Base Measurement
Variable Estimate Standard Error P-value
Intercept 71.21 2.46 <0.001
Visit -5.54 0.92 <0.001
Group NS
Interaction of Group and Visit NS
Change in Age NS
Table III.  Mixed effects modelling of Maxillary Base considering only visit (categorical), group (Treated vs Control) and the interaction of group and visit 
as explanatory variables.
Mixed effect modelling of Maxillary Base Measurement
Variable Estimate Standard Error P-value
Intercept 70.77 2.374 <0.001
Visit -4.839 0.649 <0.001
Group NS
Interaction of Group and Visit NS
Change in Age NS
Table IV.  Mixed effects modelling of Maxillary Base considering only visit (categorical), group (Treated vs Control), the interaction of group and visit and 
change in age (from initial to final visit) as explanatory variables.
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Cephalometric variable
Non-surgical 















Mean SD Mean SD Mean SD Mean SD
Maxillary skeletal
Maxillary Base (ss/OLsp) 65.7 4.1 64.8 4.8 71.3 5.5 69.2 5.5 NS NS
SNA 79.0 4.2 79.5 3.3 81.8 4.8 80.3 2.7 NS NS
Mandibular skeletal
Md base (Pg/OLsp) 75.8 6.6 75.8 7.4 82.3 8.6 85.9 8.6 NS NS
Md length (Pg-co/OLsp) 82.9 6.0 82.9 6.3 92.4 8.2 95.8 9.2 NS NS
SNB 80.5 3.8 81.3 3.0 82.2 4.3 84.3 3.9 NS NS
B point/Olsp 72.8 4.8 72.8 5.3 77.6 7.5 81.0 7.5 NS NS
SNPg 81.2 4.1 81.8 3.2 83.5 4.5 85.3 4.0 NS NS
Maxillomandibular
Mx/Mn relationship 
(ss-Pg/OLsp) -10.0 4.2 -10.9 4.3 -11.0 5.8 -16.7 5.8 NS **
ANB -1.4 2.6 -2.1 2.4 -0.5 3.0 -4.1 2.9 NS **/#
AB distance 0.5 2.2 -1.2 2.9 0.3 4.4 -6.0 4.6 * **/#
Wits -7.1 2.3 -8.0 2.0 -6.3 4.5 -11.8 4.4 NS **
Hard tissue convexity 
(n-ss-Pg) -5.2 5.9 -3.2 4.3 -4.2 7.3 -10.7 6.5 NS **
Vertical skeletal
Nasal plane angle (NL/NSL) 6.9 3.5 6.2 2.5 6.1 3.6 7.5 2.7 NS NS
Md plane angle (ML/NSL) 34.7 4.4 36.5 3.9 33.4 3.8 35.4 5.7 NS NS
Vertical jaw relation (ML/NL) 27.7 3.6 29.7 3.3 27.0 4.7 27.7 5.4 NS NS
LAFH (sp-gn/NSL) 55.9 1.9 56.6 2.0 56.6 1.9 57.4 2.6 NS NS
Skeletodental
Mx incisor horizontal (is/OLsp) 71.5 5.4 71.5 5.0 80.0 7.0 78.1 7.0 NS NS
ls.OLsp 83.8 4.9 82.8 5.3 90.7 7.0 89.4 7.8 NS NS
Mx molar horizontal (ms/OLsp) 45.5 3.8 45.2 4.0 52.4 4.8 52.8 5.4 NS NS
Md incisor horizontal (ii/OLsp) 72.4 4.3 72.5 5.6 77.9 7.7 80.0 7.4 NS NS
li.OLsp 86.2 4.9 85.8 6.0 92.4 7.7 93.6 8.3 NS NS
Md molar horizontal (mi/OLsp) 48.5 .4.0 48.4 4.5 55.8 6.3 59.3 6.1 NS NS
Dentoalveolar
Inclination max. inc. to NSL (ILis-NSL) 111.9 7.0 113.0 10.5 116.9 6.3 118.1 6.4 NS NS
Inclination mand. inc. to ML (ILii-ML) 85.3 7.4 82.6 4.6 85.7 9.0 78.3 6.1 NS **
Interdental
Overjet -1.0 2.5 -1.0 1.8 2.1 1.7 -1.9 2.1 NS **
Molar relation 
(ms/OLsp-mi/OLsp) -3.0 2.3 -3.0 1.6 -3.4 2.3 -6.5 2.4 NS **
Overbite (is-ii/OLsp) 1.7 1.9 0.2 2.2 1.3 1.7 0.7 2.8 * NS
Soft tissue
Soft tissue convexity w/out nose (n’-ss’-pg) 8.8 4.8 3.6 9.4 8.3 8.0 3.8 5.8 * *
Soft tissue convexity with nose (n’-pro-Pg’) 42.2 3.8 41.0 5.2 45.3 4.9 42.1 6.9 NS NS
ss’/OLsp 79.1 4.6 78.2 5.1 86.5 6.6 84.4 7.3 NS NS
pg’/OLsp 85.2 6.3 85.3 5.9 94.1 8.8 95.3 9.1 NS NS
Table V.  Comparison between surgical and non-surgical groups at Ti and Tf.
*p < 0.05; **p < 0.01; #Significant with the Bonferroni correction; NS = not significant
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significant difference in maxillary base values were 
observed between the treated and control groups.
In comparison with the RME/FM failure rate of 30% 
reported in previous studies,4,13,16 the failure rate within 
the current treated sample was increased at 45%. This 
may be due to selection bias within the sample, as 
patients who required orthognathic surgery had more 
complete records and were over-represented in the 
present sample.  Nonetheless, the greater long-term 
failure rate observed in the current study questions 
whether the maxilla may be manipulated, and adds 
validity to the theory that the dimensions of the 
craniofacial skeleton are genetically predetermined, as 
described many years ago by Martinek36 and Brodie.37
In a comparison of the non-surgical and surgical 
groups, the Class III skeletal discrepancy at Ti was 
greater in the surgical group, as indicated by the 
AB distance (p < 0.05) and soft tissue convexity (p 
< 0.05). This worsened with growth, as the variables 
describing the Mx/Mn relationship (p < 0.01) (ANB 
(p < 0.01), AB distance (p < 0.01), Wits (p < 0.01), 
soft and hard tissue convexity (p < 0.05), overjet (p 
< 0.01), molar relation (p < 0.01) and inclination of 
the mandibular incisors (p < 0.01)) were significantly 
different compared with the non-surgical group at Tf. 
The variables were consistent with those found by 
Stellzig-Eisenhauer et al.,38 and served as indicators 
determining whether individuals with a Skeletal 
Class III relationship can be treated surgically or non-
surgically. However, at Ti the variables suggested as 
predictors of successful RME/FM therapy, such as 
the molar relationship,39 upper incisor inclination to 
the maxillary plane, horizontal distances of labrale 
superioris to soft tissue nasion and labrale inferioris to 
sella vertical,40 were not significantly different in either 
group and possibly due to the different phenotypic 
expressions of Class III skeletal discrepancy within a 
given population.41
There are limitations associated with the present 
study. Firstly, the nature of the study is retrospective 
and longitudinal, which comes with inherent 
concerns. Secondly, although reflective of Australia’s 
multicultural population, the small sample size of 
mixed ethnicity is a confounding factor that adds 
comparison variability. Additionally, obtaining an 
untreated longitudinal Class III sample proved 
challenging and this group was fewer in number than 
the treated group.
New techniques involving novel expansion protocols 
have been proposed to expand and protract the 
maxilla,42 using a facemask with temporary anchors 
in the growing child.43-47 The treatment effects on the 
maxilla appear to be enhanced in the short term by 
applying the technique of alternating expansion and 
contraction. However, the long-term outcomes are yet 
to be reported.
Figure 3. Distribution of Change in Maxillary Base separated by group. Figure 4. Distribution of Change in Maxillary Base separated by group.
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Mean SD Mean SD P-value Significant
Age 8.76 1.06 8.79 1.32 0.926 NS
Maxillary skeletal
Maxillary Base (ss/OLsp) 65.73 4.07 64.85 4.76 0.522 NS
SNA 79.04 4.18 79.45 3.31 0.735 NS
Mandibular skeletal
Mandibular base (Pg/OLsp) 75.75 6.61 75.77 7.39 0.995 NS
Mandibular length 1 (Pg-co/OLsp) 82.88 6.01 82.86 6.27 0.995 NS
Mandibular length 2 (Pg-ar/OLsp) 81.90 5.87 81.58 5.87 0.867 NS
SNB 80.46 3.78 81.32 2.95 0.424 NS
B point/Olsp 72.83 4.82 72.84 5.33 0.995 NS
SNPg 81.15 4.07 81.79 3.22 0.583 NS
Maxillomandibular
Mx/Mn relationship (ss-Pg/OLsp) -10.02 4.20 -10.91 4.33 0.503 NS
ANB -1.41 2.60 -2.11 2.36 0.376 NS
AB distance 0.49 2.23 -1.24 2.93 0.036 *
Wits -7.10 2.33 -7.99 1.95 0.192 NS
Hard tissue convexity (n-ss-Pg) -5.15 5.93 -3.21 4.32 0.242 NS
Vertical skeletal
Nasal plane angle (NL/NSL) 6.89 3.48 6.16 2.54 0.449 NS
Mandibular plane angle (ML/NSL) 34.72 4.35 36.45 3.93 0.188 NS
Vertical jaw relation (ML/NL) 27.70 3.63 29.71 3.26 0.069 NS
LAFH (sp-gn/NSL) 55.94 1.89 56.56 2.03 0.310 NS
Skeletodental
Maxillary incisor horizontal (is/OLsp) 71.47 5.40 71.46 5.01 0.995 NS
ls.OLsp 83.80 4.86 82.77 5.28 0.516 NS
Maxillary molar horizontal (ms/OLsp) 45.53 4.02 45.24 4.46 0.813 NS
Mandibular incisor horizontal (ii/OLsp) 72.44 4.30 72.47 5.65 0.985 NS
li.OLsp 86.24 4.91 85.80 5.96 0.792 NS
Mandibular molar horizontal (mi/OLsp) 48.52 3.77 48.40 3.99 0.932 NS
Dentoalveolar
Inclination max. inc. to NSL (ILis-NSL) 111.94 7.00 112.97 10.51 0.704 NS
Inclination mand. inc. to ML (ILii-ML) 85.26 7.38 82.55 4.61 0.155 NS
Interdental
Overjet -0.97 2.52 -1.00 1.79 0.959 NS
Molar relation (ms/OLsp-mi/OLsp) -2.99 2.27 -3.01 1.57 0.975 NS
Overbite (is-ii/OLsp) 1.70 1.86 0.15 2.17 0.017 *
Soft tissue
Soft tissue convexity w/out nose  (n’-ss’-Pg) 8.78 4.80 3.55 9.36 0.036 *
Soft tissue convexity with nose  (n’-pro-Pg’) 42.17 3.80 41.03 5.22 0.415 NS
ss’/OLsp 79.11 4.57 78.22 5.12 0.556 NS
Pg’/OLsp 85.16 6.33 85.28 5.91 0.952 NS
Table VI.  Baseline comparison between surgical and non-surgical groups at Ti.
*p < 0.05; **p < 0.01; #Significant with the Bonferroni correction; NS = not significant
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Cephalometric variable
Non-surgical (N=23) Surgical (N=19)
Mean SD Mean SD P-value Significant
Age 18.02 2.41 18.24 2.23 0.758 NS
Maxillary skeletal
Maxillary Base (ss/OLsp) 71.28 5.47 69.23 5.46 0.234 NS
SNA 81.76 4.85 80.26 2.74 0.217 NS
Mandibular skeletal
Mandibular base (Pg/OLsp) 82.28 8.61 85.89 8.59 0.183 NS
Mandibular length 1 (Pg-co/OLsp) 92.42 8.21 95.80 9.17 0.216 NS
Mandibular length 2 (Pg-ar/OLsp) 91.81 8.01 94.82 9.09 0.261 NS
SNB 82.24 4.27 84.32 3.89 0.110 NS
B point/Olsp 77.58 7.50 81.03 7.51 0.146 NS
SNPg 83.50 4.54 85.34 3.97 0.174 NS
Maxillomandibular
Mx/Mn relationship (ss-Pg/OLsp) -11.00 5.83 -16.66 5.75 0.003 **
ANB -0.48 3.01 -4.05 2.88 0.0004 **/#
AB distance 0.31 4.36 -5.97 4.60 <.0001 **/#
Wits -6.30 4.47 -11.80 4.41 0.0003 **
Hard tissue convexity (n-ss-Pg) -4.15 7.34 -10.74 6.54 0.004 **
Vertical skeletal
Nasal plane angle (NL/NSL) 6.09 3.58 7.47 2.71 0.172 NS
Mandibular plane angle (ML/NSL) 33.41 3.77 35.37 5.66 0.188 NS
Vertical jaw relation (ML/NL) 27.02 4.71 27.71 5.44 0.662 NS
LAFH (sp-gn/NSL) 56.64 1.95 57.37 2.57 0.302 NS
Skeletodental
Maxillary incisor horizontal (is/OLsp) 79.98 7.67 78.10 7.36 0.394 NS
ls.OLsp 90.74 6.97 89.35 7.76 0.546 NS
Maxillary molar horizontal (ms/OLsp) 90.74 4.84 89.35 5.40 0.546 NS
Mandibular incisor horizontal (ii/OLsp) 77.91 7.67 80.00 7.36 0.377 NS
li.OLsp 92.44 7.69 93.56 8.25 0.653 NS
Mandibular molar horizontal (mi/OLsp) 55.81 6.28 59.28 6.14 0.079 NS
Dentoalveolar
Inclination max. inc. to NSL (ILis-NSL) 116.85 6.33 118.05 6.42 0.545 NS
Inclination mand. inc. to ML (ILii-ML) 85.65 8.98 78.26 6.10 0.004 **
Interdental
Overjet 2.07 1.68 -1.89 2.13 <.0001 **
Molar relation (ms/OLsp-mi/OLsp) -3.41 2.28 -6.48 2.45 0.0001 **
Overbite (is-ii/OLsp) 1.29 1.70 0.68 2.83 0.420 NS
Soft tissue
Soft tissue convexity w/out nose (n’-ss’-Pg) 8.28 7.98 3.79 5.83 0.047 *
Soft tissue convexity with nose (n’-pro-Pg’) 45.33 4.90 42.13 6.90 0.088 NS
ss’/OLsp 86.51 6.61 84.38 7.32 0.329 NS
Pg’/OLsp 94.13 8.83 95.26 9.10 0.686 NS
Table VII.  Baseline comparison between surgical and non-surgical groups at Tf.
*p < 0.05; **p < 0.01; #Significant with the Bonferroni correction; NS = not significant
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De Clerk et al. utilised titanium miniplates as 
anchorage to apply pure bone-borne orthopaedic 
forces between the maxilla and mandible by the 
application of intermaxillary elastics.43-47 De Clerk et 
al.,44 Cevidanes et al.45 and Hino et al.47 have reported 
the treatment effects of bone-anchored maxillary 
protraction to include significant maxillary protraction 
and repositioning of the condyle posteriorly with 
associated fossa remodelling. Compared with RME/
FM treatment, bone-anchored maxillary protraction 
produced a greater amount of maxillary advancement, 
improved vertical control, an inhibition of clockwise 
mandibular rotation and an absence of lower incisor 
retroclination. Moreover, the mandible exhibited a 
degeree of counter-clockwise rotation, a decrease in 
gonial angle flexure and more parallel lowering of the 
mandibular border than obsereved in facemask-only 
treatment.45,47
A three-dimensional assessment of the effects of bone-
anchored maxillary protraction reported zygomatic 
advancement as well.48,49 However, this was subject 
to individual variation described in Hino et al.’s 47 
study, which compared the growth and treatment 
effects on the midface and maxillary dentition 
produced by RME/FM and bone-anchored maxillary 
protraction in the three dimensions. Although the 
skeletal changes were greater in the bone-anchored 
group, there were several individuals in whom little 
change occurred.
At present, the long-term efficacy of bone-anchored 
maxillary protraction compared with facemask therapy 
and normal growth is yet to be clarified. Therefore, 
caution is recommended in using these approaches, 
particularly as the placement of bone plates is an 
invasive surgical procedure in a growing child.
Conclusion
1. At long-term follow-up, there were no statistically 
significant differences between RME/FM treated 
and control groups except in overjet, which was 
greater in the treated group (p < 0.05).
2. AB distance and soft tissue convexity may be 
indicators of an unfavourable Class III growth 
pattern.
3. The Mx/Mn relationship, ANB angle, AB 
distance, Wits value, soft and hard tissue 
convexity, overjet, molar relation and the 
inclination of the mandibular incisors are 
indicators of the need for orthognathic surgery 
at growth cessation.
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